These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 558736

  • 1. [Biotransformation of rifampicin in pulmonary tuberculosis patients].
    Ioffe RA.
    Antibiotiki; 1977; 22(2):177-80. PubMed ID: 558736
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis].
    Gol'dshteĭn VD, Ioffe RA, Kriukov VL.
    Probl Tuberk; 1977 Apr; (4):61-6. PubMed ID: 877065
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
    Kislitsyna NA.
    Probl Tuberk; 1985 Apr; (4):55-7. PubMed ID: 4001111
    [No Abstract] [Full Text] [Related]

  • 4. [Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations].
    Kislitsyna NA, Kotova NI.
    Probl Tuberk; 1980 Aug; (8):63-5. PubMed ID: 7403052
    [No Abstract] [Full Text] [Related]

  • 5. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT, Vakhmistrova TI, Perova TL.
    Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
    [Abstract] [Full Text] [Related]

  • 6. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 1. Excretion of rifampicin in the urine].
    Winsel K, Eule H, Werner E, Iwainsky H.
    Pharmazie; 1985 Apr; 40(4):253-6. PubMed ID: 4011658
    [Abstract] [Full Text] [Related]

  • 7. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G, Krasheninnikova MA, Kolosovskaia VP, Chukanov VI.
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract] [Full Text] [Related]

  • 8. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H, Winsel K, Werner E, Eule H.
    Scand J Respir Dis; 1974 Jan; 55(4):229-36. PubMed ID: 4438983
    [No Abstract] [Full Text] [Related]

  • 9. On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patients.
    Iwainsky H, Winsel K, Werner E, Eule H.
    Scand J Respir Dis; 1976 Jan; 57(1):5-11. PubMed ID: 1273544
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
    Modai J, Coulaud JP, Vivien JM, Berthelot G, Bergogne-Berezin E.
    Nouv Presse Med; 1978 Apr 15; 7(15):1263-7. PubMed ID: 662655
    [Abstract] [Full Text] [Related]

  • 12. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
    Nowak D, Radenbach D, Magnussen H.
    Pneumologie; 1990 Feb 15; 44 Suppl 1():497-8. PubMed ID: 2114634
    [Abstract] [Full Text] [Related]

  • 13. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.
    Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281
    [Abstract] [Full Text] [Related]

  • 14. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H, Werner E, Winsel K, Iwainsky H.
    Tubercle; 1974 Mar 11; 55(1):81-9. PubMed ID: 4620295
    [No Abstract] [Full Text] [Related]

  • 15. [Delayed results of treatment of pulmonary tuberculosis with rifampicin].
    Fréour P, Bernadou M, Chomy P.
    Gruzlica; 1974 May 11; 42(5):439-42. PubMed ID: 4464235
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [New information on the metabolism of isoniazide and rifampicin. Their therapeutical consequences (author's transl)].
    Sauvaget J, Sainte-Laudy J, Canavate A.
    Poumon Coeur; 1979 May 11; 35(5):287-92. PubMed ID: 537976
    [Abstract] [Full Text] [Related]

  • 19. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG, Esanbaev DE, Kirina SB.
    Probl Tuberk; 1983 May 11; (5):42-6. PubMed ID: 6866983
    [No Abstract] [Full Text] [Related]

  • 20. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
    Nijland HM, Ruslami R, Suroto AJ, Burger DM, Alisjahbana B, van Crevel R, Aarnoutse RE.
    Clin Infect Dis; 2007 Oct 15; 45(8):1001-7. PubMed ID: 17879915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.